Clinical Trials Logo

Epilepsy clinical trials

View clinical trials related to Epilepsy.

Filter by:

NCT ID: NCT01874600 Active, not recruiting - Epilepsy Clinical Trials

Seizure Detection and Warning System for Epilepsy Patients

Start date: July 2013
Phase:
Study type: Observational

The seizure detection and warning system is an ambulatory system designed to monitor and analyze EMG data to detect the onset of GTC seizures and to provide a warning signal to alert caregivers that a seizure is occurring.

NCT ID: NCT01870024 Completed - Epilepsy Clinical Trials

Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus

LORACLOFT
Start date: June 26, 2013
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to know on one hand if lorazepam is more (effective) than clonazepam and on the other hand if lorazepam is also effective as the association clonazepam + fosphenytoin in out-of-hospital treatment of the generalized convulsive status epilepticus in adult patients.

NCT ID: NCT01863602 Completed - Epilepsy Clinical Trials

Special Drug Use Investigation for LAMICTAL® (Long Term)

Start date: April 2009
Phase: N/A
Study type: Observational

The objectives of this post-marketing surveillance (PMS) are to grasp the actual use of lamotrigine tablets to collect safety information in the long-term use according to seizure type and concomitant antiepileptic drug (AED), and to confirm its efficacy.

NCT ID: NCT01859481 Completed - Clinical trials for Migraine Without Aura

Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study

Start date: March 2000
Phase: Phase 3
Study type: Interventional

Evaluation of headache response at 2 hours for active treated attacks for increasing dose.

NCT ID: NCT01858870 Completed - Epilepsy Clinical Trials

Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication

Start date: April 2012
Phase: N/A
Study type: Observational

Lacosamide is an antiepileptic drug approved for using like adjuvant treatment in adults epileptic crisis. Previous studies has granted to the adjuvant therapy a significant efficacy. This is an observational study, multicenter and retrospective, in patients with epilepsy. The aim of study is the evaluation of the adjuvant treatment with Lacosamide administered over 12 months. The investigators will collect information from 860 patients in 13 spanish centers. The secondary aim is assess the tolerability of treatment during 3,6 and 12 month.

NCT ID: NCT01858285 Recruiting - Epilepsy Clinical Trials

Genetics of Epilepsy and Related Disorders

Start date: November 2010
Phase:
Study type: Observational

Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to epilepsy and related disorders. These findings may help explain the broad spectrum of clinical characteristics and outcomes seen in people with epilepsy.

NCT ID: NCT01856335 Completed - Epilepsy Clinical Trials

Exercise Education for Adults With Seizure Disorders

Start date: May 10, 2013
Phase: Early Phase 1
Study type: Interventional

Study Population -People with seizures benefit from regular exercise. Exercise may help decrease the number of seizures they have. It also improves overall health and quality of life. However, people with seizure disorders often have been prevented from doing sports or other regular physical activity. They may also feel that exercise or injury can increase their risk of seizures. Researchers want to try an exercise program for people who have seizures to see if they can increase motivation to exercise which will improve overall health and may decrease the frequency of seizures. Objectives: - To see how exercise education improves motivation to exercise in people who have a history of seizures. Eligibility: - Individuals at least 18 years of age who have a history of seizures. Design: - This study involves three outpatient visits and weekly telephone calls for about 12 weeks. There will be followup calls at about 6 and 12 months after the outpatient visits. - Participants will be screened with a physical exam and medical history. They will answer questions about their current level of physical activity, mood, quality of life, and ideas about exercise. - At the first visit, participants will learn how to keep a physical activity log and seizure calendar. They will also use an activity monitor and take their pulse regularly. They will complete questionnaires about their mood and thoughts about exercise and seizures. - At the second visit, participants will set personal activity goals and learn about physical activity and seizures. They will review the physical activity log, seizure log, and activity monitor and pulse readings for the previous 4 weeks. - After the second visit, participants will receive weekly telephone calls. Each call will last about 5 minutes. These calls will ask about physical activities for the week and participants' progress toward meeting their goals. These calls will also review the seizure log. - At the third visit (12 weeks), the same tests from the first visit will be repeated. - The followup phone calls will continue to monitor participants' activity levels.

NCT ID: NCT01855178 Completed - Epilepsy Clinical Trials

Pediatric Seizure Movement Bed Alarm

PedsBedAlarm
Start date: October 2010
Phase: N/A
Study type: Observational

Nocturnal seizure and Sudden unexplained death in epilepsy patients (SUDEP) are major concerns for parents and creates anxiety and poor sleep conditions for many families dealing with epilepsy. An accurate and reliable system for alerting parents to ongoing seizure activity could make a substantial impact in quality of life and possibly reduce the mortality of epilepsy. No previous studies in the pediatric population have been performed to evaluate this type of monitoring for seizure activity. This is one of the most common questions parents ask in clinic, "Are there any alarms that can tell me when my child is having a seizure at night?" Currently the answer is no. This study has the capability to give us data that may change this answer to yes.

NCT ID: NCT01851057 Completed - Epilepsy Clinical Trials

Supporting Treatment Adherence Regimens in Pediatric Epilepsy: The STAR Trial

Start date: April 2013
Phase: N/A
Study type: Interventional

Fifty-eight percent of children with new-onset epilepsy do not take their antiepileptic drugs (AEDs) as prescribed (i.e., non-adherence). Non-adherence, which is modifiable, is associated with continued seizures, mortality, poor quality of life, and high healthcare costs. There are no adherence interventions for young children with epilepsy and their families; thus, the current proposal examines a family-based behavioral treatment focused on improving epilepsy knowledge and problem-solving around barriers to adherence in young children with epilepsy and their families with the goal of improving adherence and ultimately, seizures and quality of life. It is hypothesized that children with newly diagnosed epilepsy and their families who participate in the problem-solving intervention will have significant improvements on adherence compared to those in the education only intervention.

NCT ID: NCT01850498 Completed - Epilepsy Clinical Trials

Epilepsy Motion Sensing

Start date: May 2012
Phase: N/A
Study type: Observational

Evaluate patient motion during seizures.